Amber Jaycocks

Learn More
BACKGROUND There is evidence to suggest that antiretroviral therapy (ART) and testing for human immunodeficiency virus (HIV) reduce the probability of transmission of HIV. This has led health officials across the United States to take steps toward a test-and-treat policy. However, the extent of the benefits generated by test-and-treat is debatable, and(More)
BACKGROUND Data on effectiveness of preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)-uninfected women attempting conception with HIV-infected male partners are limited to observational studies. METHODS To explore the benefits of PrEP for conception, we developed a model to estimate the average annual probability of a woman remaining(More)
We thank Gonzalez-Serna and his colleagues for initiating a discussion on our paper that models the impact of the testand-treat policy on the human immunodeficiency virus (HIV) epidemic in Los Angeles County. Gonzalez-Serna et al contest the relevance of our findings that test-and-treat could potentially increase multidrug resistance (MDR) in Los Angeles by(More)
  • 1